Ontogenesis of UDP-glucuronosyltransferase enzymes in sheep

Comparative Biochemistry and Physiology - A Molecular and Integrative Physiology

Volumn 159, Issue 2, 2011, Pages 159-166

  Pretheeban, Manoja ^a   Hammond, Geoff ^a   Bandiera, Stelvio ^b   Riggs, Wayne ^b   Rurak, Dan ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cortisol; Hepatocyte nuclear factor 4 ; MRNA level; RT PCR; Sheep liver; UDP glucuronosyltransferases

Indexed keywords

COMPLEMENTARY DNA; CORTISONE; GLUCOCORTICOID; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A3; GLUCURONOSYLTRANSFERASE 1A4; GLUCURONOSYLTRANSFERASE 1A6; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; MESSENGER RNA; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLONE; CONTROLLED STUDY; DNA SEQUENCE; DRUG METABOLISM; ENZYME SUBSTRATE; GENE AMPLIFICATION; LIVER MICROSOME; NONHUMAN; ONTOGENY; POLYMERASE CHAIN REACTION; PRENATAL PERIOD; WESTERN BLOTTING;

OVIS ARIES;

EID: 79953706857     PISSN: 10956433     EISSN: 15314332     Source Type: Journal    
DOI: 10.1016/j.cbpa.2011.02.014     Document Type: Article

References (88)

1. Alam S.N., Roberts R.J., Fisher L.J. Age related differences in salicylamide and acetaminophen conjugation in man. J. Pediatr. 1977, 90:130-135.
2. Batt A.M., Magdalou J., Vincent-Viry M., Ouzzine M., Fournel-Gigleux S., Galteau M.M., Siest G. Drug metabolizing enzymes related to laboratory medicine: cytochromes P-450 and UDP-glucuronosyltransferases. Clin. Chim. Acta 1994, 226:171-190.
3. Battaglia E., Nowell S., Drake R.R., Magdalou J., Fournel-Gigleux S., Senay C., Radominska A. Photoaffinity labeling studies of the human recombinant UDP glucuronosyltransferase UGT1 6 with 5-azido-UDP-glucuronicacid. Drug Metab. Dispos. 1997, 25:406-411.
4. Beaulieu M., Levesque E., Tchernof A., Beatty B.G., Belanger A., Hum D.W. Chromosomal localization, structure, and regulation of the UGT2B17 gene, encoding a C19 steroid metabolizing enzyme. DNA Cell Biol. 1997, 16:1143-1154.
5. Behm M.O., Abdel-Rahman S.M., Leeder J.S., Kearns G.L. Ontogeny of phase II enzymes: UGT and SULT. Clin. Pharmacol. Ther. 2003, 73:29.
6. Belanger A., Hum D.W., Beaulieu M., Levesque E., Guillemette C., Tchernof A., Belanger G., Turgeon D., Dubois S. Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues. J. Steroid Biochem. Mol. Biol. 1998, 65:301-310.
7. Buckley D.B., Klaassen C.D. Tissue- and gender-specific mRNA expression of UDP-glucuronosyltransferases (UGTs) in mice. Drug Metab. Dispos. 2007, 35:121-127.
8. Burchell B. Isolation and purification of bilirubin UDP-glucuronyl-transferase from rat liver. FEBS Lett. 1980, 111:131-135.
9. Burchell B., Coughtrie M.W.H. UDP-glucuronosyltransferases. Pharmacol. Ther. 1989, 43:261-289.
10. Burchell B., Nebert D.W., Nelson D.R., Bock K.W., Takashi I., Jansen P.L.M., Lancet D., Mulder G.J., Chowdhury J.R., Siest G., Tephly T.R., Mackenzie P.I. The UDP glucuronosyl transferase gene superfamily: suggested nomenclature based on evolutionary divergence. DNA Cell Biol. 1991, 10:487-494.
11. Chen G., Battalion E., Senay C., Falany C.N., Radominska-Pandya A. Photoaffinity labeling probe for the substrate binding site of human phenol sulfotransferase (SULT1A1):7-Azido-4-methylcoumarin. Protein Sci. 1999, 8:2151-2157.
12. Choonara I.A., McKay P., Hain R., Rane A. Morphine metabolism in children. Br. J. Clin. Pharmacol. 1989, 28:599-604.
13. Coffman B.L., Rios G.R., King C.D., Tephly T.R. Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab. Dispos. 1997, 25:1-4.
14. Coughtrie M.W., Burchell B., Leakey J.E., Hume R. The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes. Mol. Pharmacol. 1988, 34:729-735.
15. Cui W., Aslam S., Fletcher J., Wylie D., Clinton M., Clark A.J. Stabilization of telomere length and karyotypic stability are directly correlated with the level of hTERT gene expression in primary fibroblasts. J. Biol. Chem. 2002, 277:38531-38539.
16. de Wildt S.N., Kearns G.L., Leeder J.S., van den Anker J.N. Glucuronidation in human: Pharmacogenetic and developmental aspects. Clin. Pharmacokinet. 1999, 36:439-452.
17. Ebner T., Burchell B. Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family. Drug Metab. Dispos. 1993, 21:50-55.
18. Emi Y., Ikushiro S., Iyanagi T. Drug-responsive and tissue-specific alternative expression of multiple first exons in rat UDP-glucuronosyltransferase family 1 (UGT1) gene complex. J. Biochem. 1995, 117:392-399.
19. Falany C.N., Tephly T.R. Separation, purification and characterization of three isoenzymes of UDP-glucuronyltransferase from rat liver microsomes. Arch. Biochem. Biophys. 1983, 227:248-258.
20. Gagne J.-F., Montminy V., Belanger P., Journault K., Gaucher G., Guillemette C. Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38). Mol. Pharmacol. 2002, 62:608-617.
21. Green M.D., Clarke D.J., Oturu E.M., Styczynski P.B., Jackson M.R., Burchell B., Tephly T.R. Cloning and expression of a rat liver phenobarbital-inducible UDP-glucuronosyl transferase (2B12) with specificity for monoterpenoid alcohols. Arch. Biochem. Biophys. 1995, 322:460-468.
22. Haberer L.J., Pollack G.M. Disposition and protein binding of valproic acid in the developing rat. Drug Metab. Dispos. 1994, 22:113-119.
23. Harding D., Fournel-Gigleux S., Jackson M.R., Burchell B. Cloning and substrate specificity of a human phenol UDP-glucuronosyltransferase expressed in COS-7 cells. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:8381-8385.
24. http://www.bioinformatics.org/sms2/translate.html.
25. Huang X., Miller W. A time-efficient, linear-space local similarity algorithm. Adv. Appl. Math. 1991, 12:337-357.
26. Innocenti F., Iyer L., Ramirez J., Green M.D., Ratain M.J. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7. Drug Metab. Dispos. 2001, 29:686-692.
27. Ionescu C., Caira M.R. Drug Metabolism Current Concepts 2005, Springer, Netherlands.
28. Ishizaki T., Yokochi K., Chiba K., Tabuchi T., Wagatsuma T. Placental transfer of anticonvulsants (phenobarbital, phenytoin and valproic acid) and the elimination from neonates. Pediatr. Pharmacol. 1981, 1:291-303.
29. Iwano H., Yotsumoto N., Yokota H., Yuasa A. cDNA cloning and expression of a bovine phenol UDP-glucuronosyltransferase, BovUGT1A6. Life Sci. 2001, 68(18):2131-2139.
30. Iyanagi T., Haniu M., Sogawa K., Fujii-Kuriyama Y., Watanabe S., Shively J.E., Anan K.F. Cloning and characterization of cDNA encoding 3-methylcholanthrene inducible rat mRNA for UDP-glucuronosyltransferase. J. Biol. Chem. 1986, 261:15607-15614.
31. Jinno H., Saeki M., Saito Y., Tanaka-Kagawa T., Hanioka N., Sai K., Kaniwa N., Ando M., Shirao K., Minami H., Ohtsu A., Yoshida T., Saijo N., Ozawa S., Sawada J. Functional characterization of human UDP-glucuronosyltransferase 1A9 Variant, D256N, found in Japanese cancer patients Sawada. J. Pharmacol. Exp. Ther. 2003, (Fast Forward). 10.1124/jpet.103.051250.
32. Kerdpin O., Mackenzie P.I., Bowalgaha K., Finel M., Miners J.O. Influence of N-terminal domain histidine and proline residues on the substrate selectivities of human UDP-glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10. Drug Metab. Dispos. 2009, 37(9):1948-1955.
33. Kim J., Riggs K.W., Rurak D.W. Stereo selective pharmacokinetics of fluoxetine and norfluoxetine enantiomers in pregnant sheep. Drug Metab. Dispos. 2004, 32:212-221.
34. King C.D., Green M.D., Rios G.R., Coffman B.L., Owens I.S., Bishop W.P., Tephly T.R. The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1. Arch. Biochem. Biophys. 1996, 332:92-100.
35. King C.D., Rios G.R., Green M.D., Mackenzie P.I., Tephly T.R. Comparison of stably expressed rat UGT1.1 and UGT2B1 in the glucuronidation of opioid compounds. Drug Metab. Dispos. 1997, 25(2):251-255.
36. Kobayashi T., Yokota H., Ohgiya S., Iwano H., Yuasa A. UDP-glucuronosyl transferase UGT1A7 induced in rat small intestinal mucosa by oral administration of 2-naphthoflavone. Eur. J. Biochem. 1998, 258(3):948-955.
37. Kobayashi T., Tatano A., Yokota H., Onaga T., Watanabe T., Yuasa A. Small intestinal UDP-glucuronosyltransferase sheUGT1A07: Partial purification and cDNA cloning from sheep small intestine. Arch. Biochem. Biophys. 1999, 364:143-152.
38. Krauer B., Dayer P. Fetal drug metabolism and its possible clinical implications. Clin. Pharmacokinet. 1991, 21:70-80.
39. Krishna R., Riggs K.W., Kwan E., Walker M.P.R., Rurak D.W. Pharmacokinetics of indomethacin in chronically instrumented ovine fetuses following a 3day intravenous infusion. Pharm. Res. 1995, 12:S-347.
40. Kubota T., Lewis B.C., Elliot D.J., Mackenzie P.I., Miners J.O. Critical roles of residues 36 and 40 in the phenol and tertiary amine aglycone substrate selectivities of UDP-glucuronosyltransferases 1A3 and 1A4. Mol. Pharmacol. 2007, 72:1054-1062.
41. Kumar, S., 1998. Drug disposition in the maternal-fetal unit: Studies with diphenhydramine and valproic acid in pregnant sheep. Ph.D. Thesis, University of British Columbia, Vancouver, B.C., Canada.
42. Kumar S., Wong H., Au-Yeung S., Riggs K.W., Abbott F.S., Rurak D.W. Disposition of valproic acid in maternal, fetal, and newborn sheep. II: metabolism and renal elimination. Drug Metab. Dispos. 2000, 28:857-864.
43. Kumar S., Wong H., Au-Yeung S., Riggs K.W., Abbott F.S., Rurak D.W. Disposition of valproic acid in maternal, fetal, and newborn sheep. I: placental transfer, plasma protein binding, and clearance. Drug Metab. Dispos. 2000, 28:845-856.
44. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
45. Lamb J.G., Straub P., Tukey R.H. Cloning and characterization of cDNAs encoding mouse Ugt1.6 and rabbit UGT1.6: differential induction by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Biochemistry 1994, 33:10513-10520.
46. Lewis B.C., Mackenzie P.I., Elliot D.J., Burchell B., Bhasker C.R., Miners J.O. Amino terminal domains of human UDP-glucuronosyltransferases (UGT) 2B7 and 2B15 associated with substrate selectivity and autoactivation. Biochem. Pharmacol. 2007, 73(9):1463-1473.
47. Liggins G.C. The role of cortisol in preparing the fetus for birth. Reprod. Fertil. Dev. 1994, 6:141-150.
48. T method. Cell 2001, 25(4):402-408.
49. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
50. Lu A.Y., Levin W. Partial purification of cytochromes P-450 and P-448 from rat liver microsomes. Biochem. Biophys. Res. Commun. 1972, 46:1334-1339.
51. Mackenzie P.I., Owens I.S., Burchell B., Bock K.W., Bairoch A., Belanger A., Fournel-Gigleux S., Green M., Hum D.W., Iyanagi T., Lancet D., Louisot P., Magdalou J., Chowdhury J.R., Ritter J.K., Schachter H., Tephly T.R., Tipton K.F., Nebert D.W. The UDP-glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 1997, 7(4):255-269.
52. Matsumoto J., Yokota H., Yuasa A. Developmental increases in rat hepatic microsomal UDP-glucuronosyl transferase activities toward xenoestrogens and decreases during pregnancy. Environ. Health Perspect. 2002, 110:193-196.
53. McCarver D.G., Hines R.N. Ontogeny of human drug metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms. J. Pharmacol. Exp. Ther. 2002, 300:361-366.
54. Meech R., Mackenzie P.I. Structure and function of uridine diphosphate glucuronosyltransferases. Clin. Exp. Pharmacol. Physiol. 1997, 24:907-915.
55. Miley M.J., Zielinska A.K., Keenan J.E., Bratton S.M., Radominska-Pandya A., Redinbo M.R. Crystal structure of the cofactor binding domain of the human phase II drug metabolism enzyme UDP-glucuronosyltransferase 2B7. J. Mol. Biol. 2007, 369:498-511.
56. Nau H., Rating D., Koch I., Hauser I., Helge H. Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother's milk and clinical status in neonates of epileptic mothers. J. Pharmacol. Exp. Ther. 1981, 219:768-777.
57. Norman L.J., Lye S.J., Wlodek M.E., Challis J.R.G. Changes in pituitary responses to synthetic ovine corticotrophin releasing factor in fetal sheep. Can. J. Physiol. Pharmacol. 1985, 63:1398-1403.
58. Nowell S.A., Massengill J.S., Williams S., Radominska-Pandya A., Tephly T.R., Cheng Z., Strassburg C.P., Tukey R.H., MacLeod S.L., Lang N.P., Kadlubar F.F. Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo [4, 5-b] pyridine by human microsomal UDP-glucuronosyl transferases: identification of specific UGT1A family isoforms involved. Carcinogenesis 1999, 20:1107-1114.
59. Pacifici G.M., Sawe J., Karger L., Rane A. Morphine glucuronidation in human fetal and adult liver. Eur. J. Clin. Pharmacol. 1982, 22:553-558.
60. Patana A.S., Kurkela M., Finel M., Goldman A. Mutation analysis in UGT1A9 suggests a relationship between substrate and catalytic residues in UDP-glucuronosyl transferases. Protein Eng. Des. Sel. 2008, 21:537-543.
61. Payne A.K., Morgan S.E., Gandolfi A.J., Brendel K. Biotransformation of sevoflurane by rat neonates liver slices. Drug Metab. Dispos. 1995, 23:497-500.
62. Pretheeban, M., Hammond G., Bandiera S, Riggs, W., Rurak D., submitted for publication. Ontogenesis of phase I hepatic drug metabolic enzymes in sheep. Reprod. Fertil. Dev.
63. Pritchard M., Fournel-Gigleux S., Siest G., Mackenzie P., Magdalou J. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids. Mol. Pharmacol. 1994, 45:42-50.
64. Radominsky-Pandya A.R., Czernik P.J., Little J.M., Battaglia E., Mackenzie P.I. Structural and functional studies of UDP-glucuronosyltransferase. Drug Metab. Rev. 1999, 31:817-899.
65. Ritter J.K., Chen F., Sheen Y.Y., Tran H.M., Kimura S., Yeatman M.T., Owens I.S. A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J. Biol. Chem. 1992, 267:3257-3261.
66. Rollins D.E., Glaumann H., Rane A. Acetaminophen: potentially toxic metabolite formed by human fetal and adult liver microsomes and isolated fetal liver cells. Science 1979, 205:1414-1416.
67. Rurak D.W., Wright M.R., Axelson J.E. Drug disposition and effects in the fetus. J. Dev. Physiol. 1991, 15:33-44.
68. Senay C., Ouzzine M., Battaglia E., Pless D., Cano V., Burchell B., Radominska A., Magdalou J., Fournel-Gigleux S. Arginine 52 and histidine 54 located in a conserved amino-terminal hydrophobic region (LX2-R52-G-H54-X3-V-L) are important amino acids for the functional and structural integrity of the human liver UDP-glucuronosyltransferase UGT1 6. Mol. Pharmacol. 1997, 51:406-413.
69. Shelby M.K., Cherrington N.J., Vansell N.R., Klaassen C.D. Tissue mRNA expression of the rat UDP-glucuronosyltransferase gene family. Drug Metab. Dispos. 2003, 31(3):326-333.
70. Shiratani H., Katoh M., Nakajima M., Yokoi T. Species differences in UDP-glucuronosyltransferase activities in mice and rats. Drug Metab. Dispos. 2008, 36:1745-1752.
71. Strassburg C.P., Manns M.P., Tukey R.H. Differential down-regulation of the UDP-glucuronosyltransferase 1A locus is an early event in human liver and biliary cancer. Cancer Res. 1997, 57:2979-2985.
72. Strassburg C.P., Oldhafer K., Manns M.P., Tukey R.H. Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue. Mol. Pharmacol. 1997, 52:212-220.
73. Strassburg C.P., Manns M.P., Tukey R.H. Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8. J. Biol. Chem. 1998, 273:8719-8726.
74. Strassburg C.P., Nguyen N., Manns M.P., Tukey R.H. UDP-glucuronosyltransferase activity in human liver and colon. Gastroenterology 1999, 116:149-160.
75. Strassburg C.P., Strassburg A., Nguyen N., Manns M.P., Tukey R.H. Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus. Biochem. J. 1999, 338:489-498.
76. Strassburg C.P., Strassburg A., Kneip S., Barut A., Tukey R.H., Rodeck B., Manns M.P. Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut 2002, 50(2):259-265.
77. Tephly T.R., Burchell B. UDP-glucuronosyltransferases: a family of detoxifying enzymes. TIPS 1990, 11:276-280.
78. Tukey R.H., Strassburg C.P. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu. Rev. Pharmacol. Toxicol. 2000, 40:581-616.
79. von Meyerinck L., Coffman B.L., Green M.D., Kirkpatrick R.B., Schmoldt A., Tephly T.R. Separation, purification, and characterization of digitoxigenin-monodigitoxoside UDP-glucuronosyl transferase activity. Drug Metab. Dispos. 1985, 13(6):700-704.
80. Wang L.H., Rudolph A.M., Benet L.Z. Distribution and fate of acetaminophen conjugates in fetal lambs in utero. J. Pharmacol. Exp. Ther. 1985, 235:302-307.
81. Wang L.H., Rudolph A.M., Benet L.Z. Comparative study of acetaminophen disposition in sheep at three developmental stages: the fetal, neonatal and adult periods. Dev. Pharmacol. Ther. 1990, 14:161-179.
82. Weatherill P.J., Burchell B. The separation and purification of rat liver UDP-glucuronyltransferase activities towards testosterone and oestrone. Biochem. J. 1980, 189(2):377-380.
83. Whittle W.L., Holloway A.C., Lye S.J., Gibb W., Challis J.R.G. Prostaglandin production at the onset of ovine parturition is regulated by both estrogen-independent and estrogen-dependent pathways. Endocrinology 2000, 141:3783-3791.
84. Wong H., Rurak D.W., Kumar S., Kwan E., Abbott F.S., Riggs K.W. Dose dependent pharmacokinetics and metabolism of valproic acid in newborn lambs and adult sheep. Drug Metab. Dispos. 2001, 29:664-675.
85. Wooster R., Sutherland L., Ebner T., Clarke D., Da Cruze Silva O., Burchell B. Cloning and stable expression of a new member of the human liver phenol/bilirubin: UDP-glucuronosyltransferase cDNA family. Biochem. J. 1991, 278:465-469.
86. Yokota H., Iwano H., Endo M., Kobayashi T., Inoue H., Ikushiro S., Yuasa A. Glucuronidation of the environmental bisphenol-A by an isoform of UDP-glucuronosyl transferase, UGT2B1, in the rat liver. Biochem. J. 1999, 340:405-409.
87. Yu H.-Y., Shen Y.-Z., Sugiyama Y., Hanano M. Dose-dependent pharmacokinetics of valproate in guinea pigs of different ages. Epilepsia 1987, 28:680-687.
88. Zaya M.J., Hines R.N., Stevens J.C. Epirubicin glucuronidation and UGT2B7 developmental expression. Drug Metab. Dispos. 2006, 34:2097-2101.